TrialNCT06481943
A Prospective Research Investigation of Ischemia Using MCG
- Status
- RECRUITING
- Phase
- Not listed
- Last update posted
- 09/04/2026
- Start
- 07/11/2024
- Sponsor
- SB Technology, Inc.
- Specialties
- cardiology
Conditions: Acute Coronary Syndrome
Brief summary
PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
Protocol documents and results are not hosted here. Verify every detail on ClinicalTrials.gov.